fund
THNR
In network coverage since September 21, 2026 · 4 stories
Network coverage
Launches
Defiance's autism ETF carries a 0.79% fee and an equal-weighted clinical-trial screen
The Autism Impact ETF, billed as the first of its kind, screens developed-market companies on clinical trial activity with a $250 million market-cap floor.
Passive & Indexing · Sep 28VettaFi's September rebalance cycle reshapes factor and thematic index ETFs
The Tape · Sep 22Rulebooks are selling AI while private capital buys it
Passive & Indexing · Sep 21THNR's rebalance moved the trade to the trial money